Ovarian Cancer

Our gynecologic oncologists diagnose ovarian cancer and treat it using the latest surgical procedures, including minimally invasive, robotic-assisted, and fertility-sparing approaches and clinical trials.

Our gynecologic oncologists, genetic counselors, and fertility specialists offer services for women at an increased genetic risk of developing ovarian cancer. Our experts help you carefully consider whether screening or risk-reduction surgery is right for you.

We understand how important quick decisions are in treating ovarian cancer, so we generally see you within 48 hours of your appointment request. We complement cancer care with support services, including integrative health therapies, psychological support, genetic testing, and survivorship plans.

Clinical Trials and Research Studies

Phase 2

A Phase 2 Clinical Study of TJ004309 in Combination With Atezolizumab (TECENTRIQ ) in Patients With Advanced or Metastatic Ovarian Cancers and Selected Advanced Solid Tumors

Learn More

Phase 1

A Phase 1b Multicenter Study to Determine the Dose Safety Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.

Learn More

Phase 3

AGCT1531: A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs.Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Learn More

Phase 5

A PHASE 1/2 OPEN-LABEL DOSE-ESCALATION SAFETY AND TOLERABILITY STUDY OF NC410 IN SUBJECTS WITH ADVANCED OR METASTATIC SOLID TUMORS

Learn More